These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29848173)
1. The Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study. Pilkey J; Pedersen A; Tam JW; Malik A; Wong J J Palliat Care; 2019 Apr; 34(2):96-102. PubMed ID: 29848173 [TBL] [Abstract][Full Text] [Related]
2. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial. Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508 [TBL] [Abstract][Full Text] [Related]
3. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial. Hui D; Kilgore K; Frisbee-Hume S; Park M; Liu D; Balachandran DD; Bruera E J Pain Symptom Manage; 2017 Dec; 54(6):798-805. PubMed ID: 28803087 [TBL] [Abstract][Full Text] [Related]
4. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series. Gauna AA; Kang SK; Triano ML; Swatko ER; Vanston VJ J Palliat Med; 2008 May; 11(4):643-8. PubMed ID: 18454622 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. Hui D; Hernandez F; Larsson L; Liu D; Kilgore K; Naberhuis J; Virgilio A; Reddy S; Reddy A; Dalal S; Haider A; Driver L; Azhar A; Dev R; Bruera E J Pain Symptom Manage; 2019 Oct; 58(4):605-613. PubMed ID: 31276809 [TBL] [Abstract][Full Text] [Related]
6. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial. Hui D; Xu A; Frisbee-Hume S; Chisholm G; Morgado M; Reddy S; Bruera E J Pain Symptom Manage; 2014 Feb; 47(2):209-17. PubMed ID: 23830530 [TBL] [Abstract][Full Text] [Related]
7. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer. Pinna MÁ; Bruera E; Moralo MJ; Correas MÁ; Vargas RM Am J Hosp Palliat Care; 2015 May; 32(3):298-304. PubMed ID: 24259406 [TBL] [Abstract][Full Text] [Related]
8. Inhaled nebulized and intranasal opioids for the relief of breathlessness. Bausewein C; Simon ST Curr Opin Support Palliat Care; 2014 Sep; 8(3):208-12. PubMed ID: 25004175 [TBL] [Abstract][Full Text] [Related]
9. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Graff GR; Stark JM; Grueber R Respiration; 2004; 71(6):646-9. PubMed ID: 15627879 [TBL] [Abstract][Full Text] [Related]
10. Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients. Kawaguchi J; Hamatani Y; Hirayama A; Nishimura K; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Kuroda K; Azechi M; Takahama H; Anzai T; Yasuda S; Kitaoka H; Izumi C J Cardiol; 2020 Jun; 75(6):682-688. PubMed ID: 32061472 [TBL] [Abstract][Full Text] [Related]
11. Nebulized Fentanyl for Dyspnea: A Retrospective Chart Review. Higgins EA; Young AM; Cain J; Dulin JD; Miller MM; Overstreet AN; Vaughan L; Coyne PJ J Pain Palliat Care Pharmacother; 2020 Jun; 34(2):77-81. PubMed ID: 31922438 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Oxycodone for Dyspnea in End-stage Heart Failure with Renal Insufficiency. Tanaka M; Maeba H; Senoo T; Iwasaka J; Ohkita A; Kita H; Uchitani K; Hirota Y Intern Med; 2018 Jan; 57(1):53-57. PubMed ID: 29033442 [TBL] [Abstract][Full Text] [Related]
14. Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea. Pang GS; Qu LM; Tan YY; Yee AC Am J Hosp Palliat Care; 2016 Apr; 33(3):222-7. PubMed ID: 25425740 [TBL] [Abstract][Full Text] [Related]
15. Fentanyl for the relief of refractory breathlessness: a systematic review. Simon ST; Köskeroglu P; Gaertner J; Voltz R J Pain Symptom Manage; 2013 Dec; 46(6):874-86. PubMed ID: 23742735 [TBL] [Abstract][Full Text] [Related]
16. Study protocol of a randomised controlled trial of intranasal ketamine compared with intranasal fentanyl for analgesia in children with suspected, isolated extremity fractures in the paediatric emergency department. Reynolds SL; Studnek JR; Bryant K; VanderHave K; Grossman E; Moore CG; Young J; Hogg M; Runyon MS BMJ Open; 2016 Sep; 6(9):e012190. PubMed ID: 27609854 [TBL] [Abstract][Full Text] [Related]
17. Intranasal Fentanyl Versus Placebo for Treatment of Episodic Breathlessness in Hospice Patients With Advanced Nonmalignant Diseases. Iupati S; Bridge R; Allan S; Hewitt D J Pain Symptom Manage; 2021 May; 61(5):1035-1041. PubMed ID: 33186729 [TBL] [Abstract][Full Text] [Related]
18. Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned. Smith TJ; Coyne P; French W; Ramakrishnan V; Corrigan P J Palliat Med; 2009 Sep; 12(9):771-2. PubMed ID: 19719370 [No Abstract] [Full Text] [Related]
19. Intranasal fentanyl for respiratory distress in children and adolescents with life-limiting conditions. Pieper L; Wager J; Zernikow B BMC Palliat Care; 2018 Sep; 17(1):106. PubMed ID: 30200942 [TBL] [Abstract][Full Text] [Related]